Technical Analysis for GALT - Galectin Therapeutics Inc.
|Grade||Last Price||% Change||Price Change|
GALT closed up 0.21 percent on Friday, January 18, 2019, on 66 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|Weak or Absent||Down||Up||Up|
|See historical GALT trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||50 DMA Support||Bullish||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 18||Up 3 Days in a Row||Strength||0.00%|
|Jan 18||Up 4 Days in a Row||Strength||0.00%|
|Jan 17||MACD Bullish Centerline Cross||Bullish||0.21%|
|Jan 17||Pocket Pivot||Bullish Swing Setup||0.21%|
|Jan 17||Inside Day||Range Contraction||0.21%|
|Jan 17||Wide Bands||Range Expansion||0.21%|
|Jan 17||Overbought Stochastic||Strength||0.21%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis and fatty liver disease for which the company intends to initiate a Phase I clinical trial in patients with non-alcoholic steatohepatitis; and GM-CT-01, a linear polysaccharide polymer comprising mannose and galactose that is in a Phase I/II clinical trial in Europe as a combination therapy with a tumor vaccine in patients with advanced melanoma. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more GALT news...
|52 Week High||9.49|
|52 Week Low||3.1|
|200-Day Moving Average||5.0211|
|50-Day Moving Average||4.6298|
|20-Day Moving Average||4.2025|
|10-Day Moving Average||4.614|
|Average True Range||0.3674|
|Chandelier Exit (Long, 3 ATRs )||3.9478|
|Chandelier Exit (Short, 3 ATRs )||4.2722|
|Upper Bollinger Band||5.077|
|Lower Bollinger Band||3.328|
|Percent B (%b)||0.81|
|MACD Signal Line||-0.0538|
|Market Cap||166.49 Million|
|Num Shares||35.1 Million|
|Price-to-Earnings (P/E) Ratio||-7.79|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||5.20|
|Resistance 3 (R3)||5.17||4.98||5.13|
|Resistance 2 (R2)||4.98||4.87||5.00||5.10|
|Resistance 1 (R1)||4.87||4.80||4.78||4.90||5.07|
|Support 1 (S1)||4.57||4.57||4.48||4.60||4.43|
|Support 2 (S2)||4.38||4.50||4.40||4.40|
|Support 3 (S3)||4.27||4.38||4.38|
|Support 4 (S4)||4.30|